IBALGIN DUO EFFECT

50MG/G+2MG/G CRM 50G

SÚKL code 0207891
Name of the product IBALGIN DUO EFFECT
_MA_MEDICATION_DETAIL_INFO_MED_NAME i IBALGIN DUO EFFECT
Supplement 50MG/G+2MG/G CRM 50G
Strenght 50MG/G+2MG/G
Pharmaceutical form Cream
Package 50G
Route Cutaneous use
Language of the pack Czech
Wrap type Tube
Legal status OTC medicinal products
Active substance IBUPROFEN (IBUPROFENUM)
HEPARINOIDE S (HEPARINOIDUM S)
ATC group M02AA13
ATC group name IBUPROFEN

Marketing authorisation information

Registration Number 29/ 695/99-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 12. 2021
MA Holder sanofi-aventis, s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Opella Healthcare Czech s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list